A Study of TG103 in Chinese Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 29, 2019

Primary Completion Date

November 11, 2020

Study Completion Date

November 11, 2020

Conditions

Healthy

Interventions

DRUG

TG103

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

China-Japan Friendship Hospital, Beijing

All Listed Sponsors

lead

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

INDUSTRY

NCT03990090 - A Study of TG103 in Chinese Healthy Adult Subjects | Biotech Hunter | Biotech Hunter